Reyataz and Decreased interest - from FDA reports


Summary

Decreased interest is reported only by a few people who take Reyataz. We study 8,570 people who have side effects while taking Reyataz from FDA. Among them, 1 have Decreased interest. Find out below who they are, when they have Decreased interest and more.

What to expect?

If you take Reyataz and have Decreased interest, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Reyataz and have Decreased interest

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 12, 2017

8,570 people reported to have side effects when taking Reyataz.
Among them, 1 person (0.01%) has Decreased interest


Number of reports submitted per year:

Could Reyataz cause Decreased interest?

Gender of people who have Decreased interest when taking Reyataz *:

  • female: 0.0 %
  • male: 100 %

Top conditions involved for these people *:

  • Hepatitis (1 person, 100.00%)

Top co-used drugs for these people *:

  • Truvada (1 person, 100.00%)
  • Ribavirin (1 person, 100.00%)
  • Pegasys (1 person, 100.00%)
  • Norvir (1 person, 100.00%)

Top other side effects for these people *:

  • Thinking Abnormal (1 person, 100.00%)
  • Insomnia (1 person, 100.00%)
  • Fatigue (1 person, 100.00%)
  • Appetite - Decreased (1 person, 100.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Decreased interest when taking Reyataz?

Expand the study to include all drugs with the same ingredients

Decreased interest and drugs with ingredients of atazanavir sulfate.

Expand the study to include reports from both FDA and eHealthMe

Decreased interest and Reyataz from FDA and eHealthMe reports

Reyataz

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 8,724 users)

Decreased interest

Decreased interest has been reported by people with multiple myeloma, depression, multiple sclerosis, metastases to bone, breast cancer (latest reports from 5,357 Decreased interest patients).

Browse all side effects of Reyataz

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Decreased interest

Decreased interest

Could your condition cause Decreased interest

Decreased interest

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Reyataz and have Decreased interest.

User reviews to the study

More reviews >